Abstract
Zusammenfassung.Zielsetzung: Das komorbide Auftreten der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) und substanzbezogener Störungen (SUD) ist häufig und hat einen negativen Einfluss auf den Behandlungserfolg. Studien zur Wirksamkeit ADHS-spezifischer Medikamente bei dem komorbiden Auftreten beider Störungen kommen zu uneinheitlichen Ergebnissen. Einheitlich wird allerdings eine psychotherapeutische Behandlung bei dieser Patientengruppe empfohlen, während bislang jedoch kein evaluiertes Behandlungskonzept veröffentlich wurde. Ziel dieser Arbeit ist ein Überblick zu psychotherapeutischen Ansätzen bei beiden Störungsbildern und einen Ausblick auf psychotherapeutische Ansätze für das gemeinsame Auftreten beider Störungen zu geben. Methodik: Die Zusammenstellung der Literatur erfolgte auf Basis einer Medline-, PsycINFO- und Google Scholar-Recherche (Schlüsselwörter: substance abuse, adhd, psychotherapy, therapy, methylphenidate, atomoxetine, bupropion, CBT, relapse prevention, mindfulness, MBRP, DBT). Ergebnisse: Psychotherapeutische Ansätze zur Behandlung der ADHS im Erwachsenenalter und von SUD überschneiden sich inhaltlich. Als wirksam erweisen sich CBT- und achtsamkeitsbasierte Verfahren sowie die DBT. Schlussfolgerung: Eine Kombination der oben dargestellten therapeutischen Ansätze könnte bei der Behandlung einer komorbid auftretenden ADHS und SUD sinnvoll sein. Hier bedarf es weiterer Forschungsarbeit.
Abstract.Aims: Attention-deficit hyperactivity disorder (ADHD) and substance use disorder (SUD) often co-occur, which makes treatment very difficult. Investigations into the effectiveness of ADHD medications in co-occurring ADHD and SUD have resulted in contradictory results, whereas psychotherapy is presently recommended. However, there is a lack of studies on suitable psychotherapeutic approaches. This article provides readers with information about combined psychotherapy for ADHD and SUD. Additionally, it provides a perspective on psychotherapeutic approaches for co-occurring ADHD and SUD. Methods: An overview of the literature was compiled from Medline, PsycINFO and Google Scholar (keywords: substance abuse, ADHD, psychotherapy, therapy, methylphenidate, atomoxetine, bupropion, CBT, relapse prevention, mindfulness, MBRP, DBT). Results: Psychotherapeutic approaches for ADHD and SUD overlap. CBT, mindfulness and DBT appear to be effective. Conclusions: A combination of approaches may be useful in the treatment of comorbid ADHD and SUD. Further investigation is required.
Literatur
2008). Correlates of co-occurring ADHD in drug-dependent subjects: Prevalence and features of substance dependence and psychiatric disorders. Addictive Behaviors, 33, 1199 – 1207.
(2001). Psychotherapy of Adults with Comorbid Attention-Deficit/Hyperactivity Disorder and Psychoactive Substance Use Disorder. The Journal of Psychotherapy Practice and Research, 10, 179 – 186.
(2004). Mindfulness: A proposed operational definition. Clinical Psychology: Science and Practice, 11, 230 – 241.
(2009). Mindfulness-Based Relapse Prevention for Substance Use Disorders: A pilot Efficacy Trial. Substance Abuse, 30, 295 – 305.
(2010). Mindfulness-Based Relapse Prevention for Addictive Behaviors: A Clinician′s Guide. New York: Oxford Press.
(2014). Relapse efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry, 71, 547 – 556.
(2015). Mindfulness Meditation Improves Mood, Quality of Life, and Attention in Adults with Attention Deficit Hyperactivity Disorder. BioMed Research International, 2015. Zugriff am 13. 07. 2015. Verfügbar unter www.ncbi.nlm.nih.gov/pmc/articels/PMC4475526.
(2011). Influence of Attention Deficit Hyperactivity Disorder and Conduct Disorder on Opioid Dependence and Psychiatric Comorbidity in Chronic Methadone-Maintained Patients. European Addiction Research, 17, 10 – 20.
(1978). Skill training with alcoholics. Journal of Consulting and Clinical Psychology, 46, 1092 – 1104.
(2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55, 878 – 885.
(2014). Are Mindfulness-Based Interventions Effective for Substance Use Disorders? A Systematic Review of the Evidence. Substance Use & Misuse, 49, 492 – 512.
(2012). Outcome of dialectical behaviour therapy for concurrent eating and substance use disorders. Clinical Psychology and Psychotherapy, 19, 434 – 449.
(2013). Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial. American Journal of Addiction, 22, 521 – 526.
(2014). ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood – A naturalistic long-term follow-up-study. Addictive Behaviors, 39, 325 – 328.
(2015). Behavioral Therapies for Treatment-Seeking Cannabis-Users: A Meta-Analysis of Randomized Controlled Trials. Evaluation & the Health Profession, 38, 94 – 114.
(2008). A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders. The American journal of psychiatry, 165, 179 – 187.
(2008). Dialectical Behavior Therapy for Substance Abusers. Addiction Science and Clinical Practice, 4, 39 – 47.
(2003). ADHS im Erwachsenenalter – Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Der Nervenarzt, 10, 939 – 946.
(2011). Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial. BMC Psychiatry, 11, 116.
(2003). Childhood Attention Deficit/Hyperactivity Disorder and Alcohol Dependence: A 1-Year Follow-Up. Alcohol and Alcoholism, 38, 352 – 356.
(2014). Feasibility and effectiveness of mindfulness training in adults with ADHD: a pilot study. Tijdschrift voor Psychiatrie, 56, 471 – 476.
(2002). Psychotherapy of attention deficit hyperactivity disorder in adults. European Archives of Psychiatry and Clinical Neuroscience, 252, 177 – 184.
(2004). Psychotherapie der ADHS im Erwachsenenalter. Göttingen: Hogrefe.
(2011). Reduced ADHD symptoms in adults with ADHD after structured skills training group: Results from a randomized controlled trial. Behaviour Research and Therapy, 49, 175 – 85.
(2010). The effect of mindfulness-based therapy on anxiety and depression. Journal of Consulting and Clinical Psychology, 78, 169 – 183.
(2005). Adult ADHD and Substance Abuse: Diagnostic and Treatment Issues. Substance Use & Misuse, 40 (13 – 14), 1955 – 1981.
(2005). Lifetime Prevalence and Age-of-Onset of DSM-VI Disorders in the National Comorbidity Survey Replication. Formerly Archives of General Psychiatry, 62, 593 – 602.
(2002).
(Alcohol, stimulants, nicotine, and other drugs in ADHD . In P. S. JensenJ. R. CooperEds., Attention-Deficit/Hyperactivity Disorder: State of the Sciences/Best Practices. 16-1 – 16-17. Kingston (NJ): Civic Research Institute.2014). A Pilot Study of Lis-Dexamphetamine Dimesylate (LDX/SPD489) to Facilitate Smoking Cessation in Nicotine-Dependent Adults With ADHD. Journal of Attention Disorders, 18, 158 – 168.
(2007). Influence of Attention-Deficit/Hyperactivity Disorder Symptoms on Methadone Treatment Outcome. The American Journal on Addictions, 16, 46 – 48.
(2014). Methylphenidate for ADHD in adults with substance dependence: A 24-week randomized placebo-controlled trial. Drug and Alcohol Dependence, 140, e109.
(2004) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter. Psychotherapie Psychosomatik Medizinische Psychotherapie, 54, 124 – 136.
(1998). Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD-participants. Journal of Learning Disabilities, 31, 533 – 544.
(2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31, 328 – 341.
(2004). Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors, 29, 1875 – 1882.
(2006). Treatment of methadone-maintained patients with adult ADHD: Double-blind comparison of methylphenidate, bupropion and placebo. Drug and Alcohol Dependence, 81, 137 – 148.
(2007). Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence, 87, 20 – 29.
(2015). Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder. JAMA Psychiatry, 72, 593 – 602.
(1991). Cognitive-Behavioral Treatment of Chronically Parasuicidal Borderline Patients. Formerly Archives of General Psychiatry, 48, 1060 – 1064.
(1999). Dialectical Behavior Therapy with Borderline Personality Disorder and Drug-Dependence. The American Journal of Addictions, 8, 279 – 292.
(2002). Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug and Alcohol Dependence, 67, 13 – 26.
(2009). Cognitive-Behavioral Treatment with adult alcohol and illicit drug users: A Meta-Analysis of Randomized Controlled Trials. Journal of Studies on Alcohol and Drugs, 70, 516 – 527.
(1985). Relapse prevention: Theoretical overview of the model. In G. A. MarlattJ. R. GordonEds., Relapse prevention (pp. 3 – 70). New York: Guilford.
(2010). A Placebo-Controlled Trial of Atomoxetine in Marijuana-Dependent Individuals with Attention Deficit Hyperactivity Disorder. The American Journal on Addictions, 19, 481 – 489.
(2015). Impairments, Diagnosis and Treatments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in UK Adults: Results from the Lifetime Impairment Survey. Archieves of Psychiatric Nursing, 29, 56 – 63.
(2007). Structured Group Psychotherapy in Adults With Attention Deficit Hyperactivity Disorder: Results of An Open Multicentre Study. The Journal of Nervous and Mental Disease, 195, 1013 – 1019.
(2011). Randomized Controlled Trial of Osmotic-Release Methylphenidate with CBT in Adolescents with ADHD and Substance Use Disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 903 – 914.
(2007). Sozialmedizinische Aspekte der ADHS. PsychoNeuro, 33, 390 – 394.
(2006). A Combined Treatment Approach for Adults With ADHD – Results of an Open Study of 43 Patients. Journal of Attention Disorders, 10, 150 – 159.
(2010). Cognitive Behavioral Therapy vs Relaxation With Educational Support for Medication-Treated Adults With ADHD and Persistent Symptoms. The Journal of the American Medical Association, 304, 875 – 880.
(2014). Effects of mindfulness-based cognitive therapy on neurophysiological correlates of performance monitoring in adult attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 125, 1407 – 1416.
(2004). Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen. Nervenarzt, 75, 697 – 716.
(2005). Bupropion SR for the Treatment of Substance-Abusing Outpatient Adolescents with Attention-Deficit/Hyperactivity Disorder and Mood Disorders. Journal of Child and Adolescent Psychopharmacology, 15, 777 – 786.
(2002) A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry, 36, 610 – 616.
(2010). Randomized, Controlled Trial of Atomoxetine for Attention-Deficit/Hyperactivity Disorder in Adolescents With Substance Use Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 573 – 582.
(2013). Investigating the efficacy of integrative cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry, 13, 132.
(2015). Integrated cognitive behavioral therapy for patients with Substance Use Disorder and Comorbid ADHD: Two case presentations. Addictive Behaviors, 45, 214 – 217.
(2004). Predictors of Relapse During Treatment and Treatment Completion Among Marijuana-Dependent Adolescents in an Intensive Outpatient Substance Abuse Program. Substance Abuse, 25, 53 – 59.
(1998). Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. The American Journal on Addictions, 7, 156 – 163.
(2003). Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-Analytic Review of the Literature. Pediatrics, 111, 179 – 185.
(2004). Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk and treatment issues. The Psychiatric Clinics of North America, 27, 283 – 301.
(2010). An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. Journal of ADHD Related Disorders, 1, 25 – 35.
(2011). Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of placebo-controlled trial of atomoxetine. Current Medical Research & Opinion, 27, 2309 – 2320.
(2010). Does treatment of Attention Deficit Hyperactivity Disorder (ADHD) enhance response to smoking cessation intervention in ADHD smokers? A randomized trial. The Journal of clinical psychiatry, 71, 1680 – 1688.
(2014). Randomized trial comparing mindfulness-based relapse prevention with relapse prevention for women offenders at a residential addiction treatment center. Substance Use & Misuse, 49, 536 – 46.
(2008). Mindfulness meditation training in adults and adolescents with ADHD: A feasibility study. Journal of Attention Disorders, 11, 737 – 46.
(